<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04092387</url>
  </required_header>
  <id_info>
    <org_study_id>CHRMS19-0129</org_study_id>
    <secondary_id>U54DA036114-06</secondary_id>
    <nct_id>NCT04092387</nct_id>
  </id_info>
  <brief_title>Low Nicotine Content Cigarettes in Vulnerable Populations: Women of Reproductive Age</brief_title>
  <official_title>Low Nicotine Content Cigarettes in Vulnerable Populations: Women of Reproductive Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Vermont</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Food and Drug Administration (FDA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Vermont</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite marked reductions in cigarette smoking in the general population, smoking rates among&#xD;
      economically disadvantaged women have increased. Smoking among women of reproductive age is a&#xD;
      particular concern because in addition to the usual health risks, there are additional risks&#xD;
      should they become pregnant. A national nicotine reduction policy for cigarettes has&#xD;
      considerable potential to reduce tobacco use, dependence, and improve health in these&#xD;
      smokers. Controlled trials in general population samples have demonstrated that reducing the&#xD;
      nicotine content in cigarettes can reduce cigarettes per day (CPD), dependence severity, and&#xD;
      tobacco toxicant exposure.&#xD;
&#xD;
      The goal of the proposed trial is to experimentally examine whether increasing the&#xD;
      availability and appeal of an alternative, non-combusted source of nicotine (e-cigarettes)&#xD;
      moderates the effects of altering the nicotine in cigarettes in non-pregnant female cigarette&#xD;
      smokers of childbearing age. Additionally, investigators will test whether allowing&#xD;
      participants to personalize the flavor of the e-liquid alters any moderating effects their&#xD;
      availability may have on tobacco cigarette smoking.&#xD;
&#xD;
      Daily smokers who are female, aged 18-44 years, and have a maximum educational attainment of&#xD;
      graduating high school, will be recruited at Johns Hopkins University and the University of&#xD;
      Vermont.&#xD;
&#xD;
      Investigators will study two research cigarettes referred to here as Research Cigarettes 1&#xD;
      (RC1) and Research Cigarettes 2 (RC2). One of these cigarettes will be a normal nicotine&#xD;
      content cigarette and the other will be a reduced nicotine content cigarette. Investigators&#xD;
      will study two e-cigarette conditions referred to here as E-Cigarette Condition 1 (EC1) and&#xD;
      E-Cigarette Condition 2 (EC2). Both e-cigarette conditions will involve the same commercially&#xD;
      available devices and same nicotine-containing e-liquid, but in one condition that e-liquid&#xD;
      will be available only in tobacco flavor while in the other condition that e-liquid will be&#xD;
      available in multiple flavors from which participants can choose based on personal taste&#xD;
      preference. Participants will be assigned to one of the following four study conditions: (1)&#xD;
      RC1 only; (2) RC2 only; (3) RC2 + EC1; (4) RC2 + EC2.&#xD;
&#xD;
      Participants will be asked to use only their assigned study products for 16 weeks. Outcome&#xD;
      measures include total CPD, cigarette demand assessed by behavioral economics-based purchase&#xD;
      tasks, craving, withdrawal, psychiatric symptoms, breath carbon monoxide (CO), biomarkers of&#xD;
      tobacco toxicant exposure, brain function and structure, and airway inflammation (fractional&#xD;
      nitric oxide concentration in exhaled breath [FeNO]).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 18, 2019</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Double blind dosing of tobacco cigarette nicotine levels.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Cigarettes Smoked Per Day</measure>
    <time_frame>16 weeks</time_frame>
    <description>Cigarettes per day will be assessed for use of cigarettes with different nicotine content.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">246</enrollment>
  <condition>Tobacco Use Disorder</condition>
  <arm_group>
    <arm_group_label>RC 1 only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Research cigarettes #1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RC 2 only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Research Cigarettes #2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RC 2 + EC 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Research Cigarettes #2 plus E-cigarettes #1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RC 2 + EC 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Research Cigarettes #2 plus E-cigarettes #2</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cigarettes with varying nicotine content</intervention_name>
    <description>1) Altering the nicotine content of the tobacco research cigarettes</description>
    <arm_group_label>RC 1 only</arm_group_label>
    <arm_group_label>RC 2 + EC 1</arm_group_label>
    <arm_group_label>RC 2 + EC 2</arm_group_label>
    <arm_group_label>RC 2 only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>E-Cigarettes</intervention_name>
    <description>1) Altering the availability of e-cigarettes; 2) Altering option to personalize the e-liquid in the e-cig conditions</description>
    <arm_group_label>RC 2 + EC 1</arm_group_label>
    <arm_group_label>RC 2 + EC 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female&#xD;
&#xD;
          -  21 to 44 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Male&#xD;
&#xD;
          -  Under 21 years old&#xD;
&#xD;
          -  Over 44 years old&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Participants must be female.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen T. Higgins, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Vermont</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Catherine Markesich</last_name>
    <phone>8026569981</phone>
    <email>cmarkesi@uvm.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dustin Lee, Ph.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Vermont</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catie Markesich</last_name>
      <phone>802-656-9981</phone>
      <email>cmarkesi@uvm.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>September 13, 2019</study_first_submitted>
  <study_first_submitted_qc>September 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2019</study_first_posted>
  <last_update_submitted>February 22, 2021</last_update_submitted>
  <last_update_submitted_qc>February 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Vermont</investigator_affiliation>
    <investigator_full_name>Stephen T. Higgins, PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Biomarkers of Exposure</keyword>
  <keyword>Compensatory Smoking</keyword>
  <keyword>Nicotine Dependence</keyword>
  <keyword>Reduced Nicotine Cigarettes</keyword>
  <keyword>Tobacco Withdrawal</keyword>
  <keyword>Women</keyword>
  <keyword>Health Disparities</keyword>
  <keyword>Vulnerable Populations</keyword>
  <keyword>E-Cigarettes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

